Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano… - Disease models & …, 2015 - journals.biologists.com
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, EG Magny… - 2015 - digital.csic.es
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano… - Disease Models & …, 2015 - search.proquest.com
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, E Magny, JP Couso… - sussex.figshare.com
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

[HTML][HTML] Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, E Magny… - Disease Models & …, 2015 - ncbi.nlm.nih.gov
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano… - Disease models & …, 2015 - pubmed.ncbi.nlm.nih.gov
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, E Magny… - Disease Models & …, 2015 - hal.science
Up to 80% of myotonic dystrophy type 1 (DM1) patients will develop cardiac abnormalities at
some point during the progression of their disease. The most common of them are varying …

Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.

M Chakraborty, E Selma-Soriano, E Magny… - Disease Models & …, 2015 - europepmc.org
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

[PDF][PDF] Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, E Magny, JP Couso… - 2015 - academia.edu
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …

[PDF][PDF] Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction

M Chakraborty, E Selma-Soriano, E Magny, JP Couso… - 2015 - cyberleninka.org
Up to 80% of individuals with myotonic dystrophy type 1 (DM1) will develop cardiac
abnormalities at some point during the progression of their disease, the most common of …